On August 10, 2020 Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) reported that its second quarter 2020 financial results will be released on Friday, August 14, 2020 (Press release, Titan Pharmaceuticals, AUG 10, 2020, View Source [SID1234563367]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Titan will host a live conference call to discuss the financial results and provide a general business review the same day, August 14, 2020, at 9:00 a.m. PT / 12:00 p.m. ET. The call will be hosted by Sunil Bhonsle, president and CEO; Kate Beebe DeVarney, Ph.D., executive vice president and chief scientific officer; Brian Crowley, vice president of finance; Joe Schrei, executive director, commercial operations; Mike Fritz, national sales director; and Marc Rubin, M.D., executive chairman. A summary of the second quarter financial results and other highlights will be included in a press release to be issued prior to the call.

The live webcast and a replay of the call may be accessed by visiting View Source The call can also be accessed by dialing 1-888-317-6003 (or 1-412-317-6061 from outside the U.S.) ten minutes prior to the start time, and providing passcode 8493149.